doi: 10.1227/NEU.0000000000000577
References McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, Harding JW
The Lancet Global Health 2014;2:323-33
Traditional oral glutathione is poorly absorbed (only ~10% reaches the bloodstream), while IV therapy is costly and temporary
GHK-Cu Injection vs Topical Application: What Research Shows One of the most common questions in GHK-Cu research literature concerns the route of administration and whether topical or injectable (subcutaneous) delivery produces meaningfully different outcomes
The delivery method depends on your specific health goals